CYTOMX THERAPEUTICS I
0.9603
25-November-24 15:45:01
15 minutes delayed
Stocks
+0.0703
+7.90%
Today's range
0.8900 - 0.9950
ISIN
N/A
Source
NASDAQ
-
CytomX Therapeutics to Report First Quarter 2022 Financial Results on May 5, 2022
28 Apr 2022 07:00:02 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of Directors
14 Apr 2022 15:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
23 Mar 2022 15:15:00 By Nasdaq GlobeNewswire
-
17 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
01 Mar 2022 15:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Cowen 42nd Annual Healthcare Conference
28 Feb 2022 07:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
22 Feb 2022 07:00:02 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
16 Feb 2022 07:00:01 By Nasdaq GlobeNewswire
-
07 Feb 2022 08:00:01 By Nasdaq GlobeNewswire
-
19 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
05 Jan 2022 07:00:03 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming November Investor Conferences
11 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
04 Nov 2021 15:15:01 By Nasdaq GlobeNewswire
-
01 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Announce Third Quarter 2021 Financial Results on November 4, 2021
28 Oct 2021 07:00:03 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
18 Oct 2021 07:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Appoints Dr. Alan Ashworth to Board of Directors
04 Oct 2021 07:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
16 Sep 2021 07:00:02 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
07 Sep 2021 07:00:02 By Nasdaq GlobeNewswire